Ticker: ACB

Aurora Cannabis Inc.

Healthcare Healthcare Drug Manufacturers - Specialty & Generic
Price 2.67
Reco Sell Potential 20 Risk 80 Updated 2026-07-25

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Aurora Cannabis Inc. operates in the healthcare sector, focusing on the production and distribution of cannabis products for medical and recreational use. Its core offerings include dried flower, oils, and edibles, catering to both consumers and healthcare providers. The company generates revenue primarily through the sale of these cannabis products, with significant operations in North America. Aurora also engages in research and development to enhance its product portfolio and market reach.

Investment Profile

The investment profile of Aurora Cannabis Inc. is more aligned with growth investors, given its focus on expanding market presence and product innovation. The company currently does not offer dividends, which may not appeal to income-focused investors. Its performance metrics indicate a higher risk profile, suggesting that potential investors should be prepared for volatility.

Fundamental metrics (experimental) Updated: 2026-07-27
EPS (TTM) — earnings per share for the last 12 months, $
-2.23
Revenue QoQ — quarter-over-quarter revenue growth
-59.5%
EPS surprise
-914.1%
20d volatility
1.7%
AI recommendation changes
Date Before After Reason
2026-06-09 Hold Sell Weak fundamentals and negative momentum raise significant risk.
2026-06-01 Sell Hold Weak fundamentals and negative momentum raise concerns.
2026-05-24 Hold Sell Weak fundamentals and negative momentum raise significant risk.
News Page 1 of 1

Nothing yet